Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Perrigo
PRGO
|
+$672M |
| 2 |
Merck
MRK
|
+$608M |
| 3 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$384M |
| 4 |
Las Vegas Sands
LVS
|
+$378M |
| 5 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$303M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ralph Lauren
RL
|
+$518M |
| 2 |
eBay
EBAY
|
+$474M |
| 3 |
Estee Lauder
EL
|
+$435M |
| 4 |
Goldman Sachs
GS
|
+$323M |
| 5 |
TechnipFMC
FTI
|
+$304M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.03% |
| 2 | Consumer Discretionary | 13.85% |
| 3 | Communication Services | 11.23% |
| 4 | Technology | 10.46% |
| 5 | Energy | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Chevron
CVX
$382B
| $3.19M | ﹤0.01% |
26,797
+167
| +0.6% | +$19.4K |
|
552
TG Therapeutics
TGTX
$8.19B
| $3.15M | ﹤0.01% |
456,806
+1,535
| +0.3% | +$9.09K |
|
553
Berkshire Hathaway Class B
BRK.B
$1.1T
| $3.08M | ﹤0.01% |
24,660
-255
| -1% | -$29.8K |
|
554
Piper Sandler
PIPR
$4.99B
| $2.94M | ﹤0.01% |
257,164
-39,096
| -13% | -$398K |
|
555
Eli Lilly
LLY
$1.08T
| $2.94M | ﹤0.01% |
50,010
-18,373
| -27% | -$1.03M |
|
556
Bloomin' Brands
BLMN
$754M
| $2.85M | ﹤0.01% |
118,197
-4,397
| -4% | -$104K |
|
557
Teledyne Technologies
TDY
$29.2B
| $2.83M | ﹤0.01% |
29,025
-102,830
| -78% | -$9.75M |
|
558
Blackrock
BLK
$167B
| $2.78M | ﹤0.01% |
8,834
+2,800
| +46% | +$856K |
|
|
JIVE
559
DELISTED
Jive Software, Inc.
JIVE
| $2.77M | ﹤0.01% |
345,998
-1,254,687
| -78% | -$11.3M |
|
560
MacroGenics
MGNX
$233M
| $2.75M | ﹤0.01% |
98,940
+334
| +0.3% | +$11.8K |
|
|
BDBD
561
DELISTED
BOULDER BRANDS INC
BDBD
| $2.6M | ﹤0.01% |
147,332
+18,960
| +15% | +$291K |
|
|
XNPT
562
DELISTED
XENOPORT, INC.
XNPT
| $2.55M | ﹤0.01% |
492,365
+1,642
| +0.3% | +$9.9K |
|
563
Meritage Homes
MTH
$4.78B
| $2.54M | ﹤0.01% |
121,420
-23,558
| -16% | -$537K |
|
564
Rogers Corp
ROG
$2.09B
| $2.53M | ﹤0.01% |
40,503
-14,537
| -26% | -$881K |
|
|
OCRX
565
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $2.51M | ﹤0.01% |
238,152
| – | – |
|
566
Arch Capital
ACGL
$35.7B
| $2.48M | ﹤0.01% |
+129,102
| New | +$2.39M |
|
|
TRAK
567
DELISTED
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
| $2.45M | ﹤0.01% |
49,774
-740
| -1% | -$37.1K |
|
568
CSX Corp
CSX
$94B
| $2.43M | ﹤0.01% |
252,084
-125,712
| -33% | -$1.17M |
|
|
INFN
569
DELISTED
Infinera Corporation Common Stock
INFN
| $2.43M | ﹤0.01% |
267,771
-2,812
| -1% | -$24.6K |
|
570
Cytokinetics
CYTK
$10.6B
| $2.38M | ﹤0.01% |
+250,000
| New | +$2.26M |
|
|
571
PUT
Cytokinetics
CYTK
$10.6B
| $2.38M | ﹤0.01% |
+250,000
| New | +$2.26M |
|
|
NAK
572
Northern Dynasty Minerals
NAK
$773M
| $2.37M | ﹤0.01% |
2,417,149
-37,289
| -2% | -$46.4K |
|
|
SCTY
573
DELISTED
SolarCity Corporation
SCTY
| $2.37M | ﹤0.01% |
+37,830
| New | +$2.73M |
|
574
Provident Financial Services
PFS
$3.14B
| $2.3M | ﹤0.01% |
125,324
+18,670
| +18% | +$338K |
|
575
Glacier Bancorp
GBCI
$6.36B
| $2.29M | ﹤0.01% |
78,772
+12,694
| +19% | +$357K |
|
Similar funds
Jennison Associates's Q1 2014 Portfolio in Review
As of Q1 2014, Jennison Associates held 826 positions worth $105B, up 2.6% from $102B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Jennison Associates's Q1 2014 filing shows 122 new, 275 increased, 321 reduced and 94 closed positions. Its largest new stake was Perrigo: 4,257,843 shares worth $659M. The largest sale was Ralph Lauren, an estimated $518M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q1 2014 buy was Perrigo: 4,257,843 shares worth $659M.
- Jennison Associates added most to Merck in Q1 2014, an estimated $608M increase.
- Jennison Associates's biggest Q1 2014 reduction was Estee Lauder, cutting an estimated $435M.
- Jennison Associates fully exited Ralph Lauren in Q1 2014, selling an estimated $518M.
- Jennison Associates's ten largest holdings make up 18% of its $105B portfolio in Q1 2014.
- Jennison Associates opened 122 new positions and closed 94 in Q1 2014.
- Jennison Associates's portfolio value rose 2.6% quarter-over-quarter to $105B.
Based on Jennison Associates's 13F filing for Q1 2014, filed 7 May 2014.